title: CYP2D6 genotype should not be used to determine endocrine therapy in postmenopausal breast cancer patients.
authors.affiliation: Breast Oncology Program, University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, USA. jimmyrae@umich.edu
authors.forename: J M
authors.initials: JM
authors.lastname: Rae
mesh_terms: D001943:Breast Neoplasms / Q000188:drug therapy* / Q000235:genetics*; D019389:Cytochrome P-450 CYP2D6 / Q000235:genetics*; D004965:Estrogen Antagonists / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D005260:Female; D005838:Genotype; D006801:Humans; D017698:Postmenopause; D013629:Tamoxifen / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*
chemical_list: D004965:Estrogen Antagonists; D013629:Tamoxifen; D019389:Cytochrome P-450 CYP2D6